MYBL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.438800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.314400E-01
Normal-vs-Stage2
4.419600E-01
Normal-vs-Stage3
3.795400E-01
Normal-vs-Stage4
4.160600E-01
Stage1-vs-Stage2
8.310200E-01
Stage1-vs-Stage3
8.847500E-02
Stage1-vs-Stage4
6.478800E-01
Stage2-vs-Stage3
2.799900E-04
Stage2-vs-Stage4
6.685600E-01
Stage3-vs-Stage4
1.719980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.465800E-01
Normal-vs-AfricanAmerican
4.415800E-01
Normal-vs-Asian
3.925600E-01
Caucasian-vs-AfricanAmerican
9.162600E-01
Caucasian-vs-Asian
3.075600E-03
AfricanAmerican-vs-Asian
6.254400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.327000E-01
Normal-vs-Female
4.592800E-01
Male-vs-Female
1.849030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.356800E-01
Normal-vs-Age(41-60Yrs)
4.465600E-01
Normal-vs-Age(61-80Yrs)
4.430400E-01
Normal-vs-Age(81-100Yrs)
4.512400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.994000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.279000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.231400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.378600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.921800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.706600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.430600E-01
Normal-vs-Daily Drinker
4.200800E-01
Normal-vs-Weekly Drinker
4.188800E-01
Normal-vs-Occasional Drinker
4.633800E-01
Normal-vs-Social Drinker
4.435000E-01
Non Drinker-vs-Daily Drinker
4.366400E-01
Non Drinker-vs-Weekly Drinker
4.348600E-01
Non Drinker-vs-Occasional Drinker
6.398000E-01
Non Drinker-vs-Social Drinker
9.825600E-01
Daily Drinker-vs-Weekly Drinker
9.506600E-01
Daily Drinker-vs-Occasional Drinker
2.334800E-01
Daily Drinker-vs-Social Drinker
3.289400E-01
Weekly Drinker-vs-Occasional Drinker
2.357600E-01
Weekly Drinker-vs-Social Drinker
3.613200E-01
Occasional Drinker-vs-Social Drinker
6.407000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.713200E-01
Normal-vs-Grade 2
9.954600E-01
Normal-vs-Grade 3
9.960200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.707000E-01
Grade 1-vs-Grade 3
8.853200E-01
Grade 1-vs-Grade 4
9.713200E-01
Grade 2-vs-Grade 3
9.914800E-01
Grade 2-vs-Grade 4
9.954600E-01
Grade 3-vs-Grade 4
9.960200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.516600E-01
Normal-vs-NonDiabetic
4.367200E-01
Diabetic-vs-NonDiabetic
5.265800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.242600E-01
Normal-vs-NoPancreatitis
4.383400E-01
Pancreatitis-vs-NoPancreatitis
4.106600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.580800E-01
Normal-vs-N1
4.406000E-01
N0-vs-N1
4.300200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.308200E-01
Normal-vs-TP53-NonMutant
4.415400E-01
TP53-Mutant-vs-TP53-NonMutant
7.041200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
